Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-02-25 @ 7:06 PM
Study NCT ID:
NCT02930902
Status:
COMPLETED
Last Update Posted:
2023-02-09
First Post:
2016-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Resectable Pancreatic Carcinoma | View |
| None | Stage I Pancreatic Cancer AJCC v6 and v7 | View |
| None | Stage IA Pancreatic Cancer AJCC v6 and v7 | View |
| None | Stage IB Pancreatic Cancer AJCC v6 and v7 | View |
| None | Stage II Pancreatic Cancer AJCC v6 and v7 | View |
| None | Stage IIA Pancreatic Cancer AJCC v6 and v7 | View |
| None | Stage IIB Pancreatic Cancer AJCC v6 and v7 | View |
Keywords: